2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Mixed Dyslipidemia: new trials by email Literature Review of Mixed Dyslipidemia trials Research Report on Mixed Dyslipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia ARO-APOC3, Placebo - Mixed Dyslipidemia | Phase 2 | Completed | Arrowhead Pharmaceuticals | 353 | 2021-09-28 | 2026-04-14 |
| Study of ARO-ANG3 in Adults With Mixed Dyslipidemia ARO-ANG3, Placebo - Mixed Dyslipidemia | Phase 2 | Completed | Arrowhead Pharmaceuticals | 204 | 2021-06-28 | 2025-12-03 |
plozasiran (1)
Australia (2) · Canada (2) · New Zealand (2) · United States (2) · Hungary (1) · Poland (1)